Clinical Trial Update: Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis? [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial investigating whether the PET tracer [18F]-DPA-714 can serve as a marker of neuroinflammation in autoimmune encephalitis, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis

Drugs mentioned

• [18F]-DPA-714 PET (DPA-714 radiotracer)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Autoimmune Encephalitis (AE) | Phase 2 | Status: NOT_YET_RECRUITING